A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy

Rob J. Van Geest, Sarit Y. Lesnik-Oberstein, H. Stevie Tan, Marco Mura, Roel Goldschmeding, Cornelis J.F. Van Noorden, Ingeborg Klaassen, Reinier O. Schlingemann

Research output: Contribution to journalArticlepeer-review

111 Scopus citations

Fingerprint

Dive into the research topics of 'A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy'. Together they form a unique fingerprint.

Medicine & Life Sciences